miR-106a-5p Inhibits the Proliferation and Migration of Astrocytoma Cells and Promotes Apoptosis by Targeting FASTK

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Zhi, Feng ^a   Zhou, Guangxin ^b   Shao, Naiyuan ^a   Xia, Xiwei ^a   Shi, Yimin ^a   Wang, Qiang ^a   Zhang, Yi ^a   Wang, Rong ^a   Xue, Lian ^a   Wang, Suinuan ^a   Wu, Sujia ^b   Peng, Ya ^a   Yang, Yilin ^a  

^a THE THIRD AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ACTIVATED PROTEIN SERINE THREONINE KINASE; MESSENGER RNA; MICRORNA; MICRORNA 106A 5P; PROTEIN SERINE THREONINE KINASE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; ASTROCYTOMA; ASTROCYTOMA CELL; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG PROTEIN BINDING; DRUG TARGETING; FASTK GENE; GAIN OF FUNCTION MUTATION; GENE EXPRESSION; GENE INACTIVATION; GENE TARGETING; HUMAN; HUMAN CELL; KAPLAN MEIER METHOD; LOSS OF FUNCTION MUTATION; MICROARRAY ANALYSIS; RNA ANALYSIS; RNA GENE; RNA INTERFERENCE; UPREGULATION;

3' UNTRANSLATED REGIONS; APOPTOSIS; ASTROCYTOMA; BASE SEQUENCE; BINDING SITES; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MICRORNAS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN-SERINE-THREONINE KINASES; RNA INTERFERENCE; TRANSCRIPTOME;

EID: 84883203271     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072390     Document Type: Article

References (43)

1. Wen PY, Kesari S, (2008) Malignant gliomas in adults. N Engl J Med 359: 492-507.
2. Gabayan AJ, Green SB, Sanan A, Jenrette J, Schultz C, et al. (2006) GliaSite brachytherapy for treatment of recurrent malignant gliomas: a retrospective multi-institutional analysis. Neurosurgery 58: 701-709; discussion 701-709.
3. Hatanpaa KJ, Burma S, Zhao D, Habib AA, (2010) Epidermal growth factor receptor in glioma: signal transduction, neuropathology, imaging, and radioresistance. Neoplasia 12: 675-684.
4. Endersby R, Baker SJ, (2008) PTEN signaling in brain: neuropathology and tumorigenesis. Oncogene 27: 5416-5430.
5. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
6. Ryan BM, Robles AI, Harris CC, (2010) Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer 10: 389-402.
7. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435: 834-838.
8. Zhi F, Chen X, Wang S, Xia X, Shi Y, et al. (2010) The use of hsa-miR-21, hsa-miR-181b and hsa-miR-106a as prognostic indicators of astrocytoma. Eur J Cancer 46: 1640-1649.
9. Kim BH, Hong SW, Kim A, Choi SH, Yoon SO (2012) Prognostic implications for high expression of oncogenic microRNAs in advanced gastric carcinoma. J Surg Oncol.
10. Wang Z, Liu M, Zhu H, Zhang W, He S, et al. (2012) miR-106a Is frequently upregulated in gastric cancer and inhibits the extrinsic apoptotic pathway by targeting FAS. Mol Carcinog.
11. Yao Y, Suo AL, Li ZF, Liu LY, Tian T, et al. (2009) MicroRNA profiling of human gastric cancer. Mol Med Report 2: 963-970.
12. Xiao B, Guo J, Miao Y, Jiang Z, Huan R, et al. (2009) Detection of miR-106a in gastric carcinoma and its clinical significance. Clin Chim Acta 400: 97-102.
13. Guo J, Miao Y, Xiao B, Huan R, Jiang Z, et al. (2009) Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. J Gastroenterol Hepatol 24: 652-657.
14. Kim K, Chadalapaka G, Lee SO, Yamada D, Sastre-Garau X, et al. (2012) Identification of oncogenic microRNA-17-92/ZBTB4/specificity protein axis in breast cancer. Oncogene 31: 1034-1044.
15. Wang F, Zheng Z, Guo J, Ding X, (2010) Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor. Gynecol Oncol 119: 586-593.
16. Feng B, Dong TT, Wang LL, Zhou HM, Zhao HC, et al. (2012) Colorectal Cancer Migration and Invasion Initiated by microRNA-106a. PLoS One 7: e43452.
17. Donnem T, Fenton CG, Lonvik K, Berg T, Eklo K, et al. (2012) MicroRNA signatures in tumor tissue related to angiogenesis in non-small cell lung cancer. PLoS One 7: e29671.
18. Hummel R, Hussey DJ, Michael MZ, Haier J, Bruewer M, et al. (2011) MiRNAs and their association with locoregional staging and survival following surgery for esophageal carcinoma. Ann Surg Oncol 18: 253-260.
19. Diaz R, Silva J, Garcia JM, Lorenzo Y, Garcia V, et al. (2008) Deregulated expression of miR-106a predicts survival in human colon cancer patients. Genes Chromosomes Cancer 47: 794-802.
20. Yang G, Zhang R, Chen X, Mu Y, Ai J, et al. (2011) MiR-106a inhibits glioma cell growth by targeting E2F1 independent of p53 status. J Mol Med.
21. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, et al. (2005) Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 33: e179.
22. Tusher VG, Tibshirani R, Chu G, (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98: 5116-5121.
23. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB, (2003) Prediction of mammalian microRNA targets. Cell 115: 787-798.
24. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, et al. (2005) Combinatorial microRNA target predictions. Nat Genet 37: 495-500.
25. John B, Enright AJ, Aravin A, Tuschl T, Sander C, et al. (2004) Human MicroRNA targets. PLoS Biol 2: e363.
26. Zhi F, Gong G, Xu Y, Zhu Y, Hu D, et al. (2012) Activated beta-catenin Forces N2A Cell-derived Neurons Back to Tumor-like Neuroblasts and Positively Correlates with a Risk for Human Neuroblastoma. Int J Biol Sci 8: 289-297.
27. Wang K, Li P, Dong Y, Cai X, Hou D, et al. (2011) A microarray-based approach identifies ADP ribosylation factor-like protein 2 as a target of microRNA-16. J Biol Chem 286: 9468-9476.
28. Brown BD, Gentner B, Cantore A, Colleoni S, Amendola M, et al. (2007) Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state. Nat Biotechnol 25: 1457-1467.
29. Calin GA, Croce CM, (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866.
30. Chitwood DH, Timmermans MC, (2010) Small RNAs are on the move. Nature 467: 415-419.
31. Mendell JT, (2008) miRiad roles for the miR-17-92 cluster in development and disease. Cell 133: 217-222.
32. Olive V, Jiang I, He L, (2010) mir-17-92, a cluster of miRNAs in the midst of the cancer network. Int J Biochem Cell Biol 42: 1348-1354.
33. Tian Q, Taupin J, Elledge S, Robertson M, Anderson P, (1995) Fas-activated serine/threonine kinase (FAST) phosphorylates TIA-1 during Fas-mediated apoptosis. J Exp Med 182: 865-874.
34. Kedersha NL, Gupta M, Li W, Miller I, Anderson P, (1999) RNA-binding proteins TIA-1 and TIAR link the phosphorylation of eIF-2 alpha to the assembly of mammalian stress granules. J Cell Biol 147: 1431-1442.
35. Li W, Kedersha N, Chen S, Gilks N, Lee G, et al. (2004) FAST is a BCL-X(L)-associated mitochondrial protein. Biochem Biophys Res Commun 318: 95-102.
36. Simarro M, Mauger D, Rhee K, Pujana MA, Kedersha NL, et al. (2007) Fas-activated serine/threonine phosphoprotein (FAST) is a regulator of alternative splicing. Proc Natl Acad Sci U S A 104: 11370-11375.
37. Li W, Simarro M, Kedersha N, Anderson P, (2004) FAST is a survival protein that senses mitochondrial stress and modulates TIA-1-regulated changes in protein expression. Mol Cell Biol 24: 10718-10732.
38. Izquierdo JM, Valcarcel J, (2007) Fas-activated serine/threonine kinase (FAST K) synergizes with TIA-1/TIAR proteins to regulate Fas alternative splicing. J Biol Chem 282: 1539-1543.
39. Loh SH, Francescut L, Lingor P, Bahr M, Nicotera P, (2008) Identification of new kinase clusters required for neurite outgrowth and retraction by a loss-of-function RNA interference screen. Cell Death Differ 15: 283-298.
40. Trauth BC, Klas C, Peters AM, Matzku S, Moller P, et al. (1989) Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245: 301-305.
41. Salvesen GS, Dixit VM, (1999) Caspase activation: the induced-proximity model. Proc Natl Acad Sci U S A 96: 10964-10967.
42. Lee KH, Feig C, Tchikov V, Schickel R, Hallas C, et al. (2006) The role of receptor internalization in CD95 signaling. EMBO J 25: 1009-1023.
43. Brint E, O'Callaghan G, Houston A (2013) Life in the Fas lane: differential outcomes of Fas signaling. Cell Mol Life Sci.